ID
25338
Description
Study ID: 101468/191 Clinical Study ID: SKF-101468/191 Study Title:A 12 Week, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Ropinirole in Subjects with Restless Legs Syndrome (RLS) Suffering from Periodic Leg Movements of Sleep (PLMS) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication: Restless Legs Syndrome
Keywords
Versions (2)
- 9/1/17 9/1/17 -
- 9/1/17 9/1/17 -
Uploaded on
September 1, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
GSK Ropinirole in Subjects with Restless Legs Syndrome 101468/191 Week 12 Day (Form 16)
GSK Ropinirole in Subjects with Restless Legs Syndrome 101468/191 Week 12 Day (Form 16)
Description
Investigational Product Record since last visit
Description
Investigational Product Record since last visit
Data type
boolean
Description
RSL Rating Scale
Description
Vital Signs
Description
Weight
Data type
float
Measurement units
- kg/lbs
Description
Pulse
Data type
integer
Measurement units
- beats/min
Description
Sitting Blood Pressure systolic
Data type
integer
Measurement units
- mmHg
Description
Sitting Blood pressure diastolic
Data type
integer
Measurement units
- mmHg
Description
Medical Procedures
Data type
boolean
Description
Concomitant Medication
Data type
boolean
Description
Adverse Experiences
Data type
boolean
Description
Laboratory Evaluation
Description
Pregnancy Dipstick
No comments